{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:59:02Z","timestamp":1791849542371,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.clnesp.2021.08.028","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T12:19:55Z","timestamp":1630930795000},"page":"519-526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"46","author":[{"given":"Aanchal","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shajith","family":"Anoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irshad Ahmad","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5785-5833","authenticated-orcid":false,"given":"Anoop","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clnesp.2021.08.028_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clnesp.2021.08.028_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40842-020-00097-1","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand?","volume":"6","author":"Tomah","year":"2020","journal-title":"Clin Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.clnesp.2021.08.028_bib3","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.18520\/cs\/v113\/i07\/1303-1310","article-title":"Non-alcoholic fatty liver disease in Asian Indians: relationship with insulin resistance, diabetes and cardiovascular risk","volume":"113","author":"Bhatt","year":"2017","journal-title":"Curr Sci"},{"issue":"48","key":"10.1016\/j.clnesp.2021.08.028_bib4","doi-asserted-by":"crossref","first-page":"18273","DOI":"10.1073\/pnas.0608537103","article-title":"Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men","volume":"103","author":"Petersen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.clnesp.2021.08.028_bib5","first-page":"522","article-title":"Diabetes in developing countries","volume":"11","author":"Misra","year":"2019","journal-title":"J\u00a0Diabetes"},{"issue":"11 Suppl 1","key":"10.1016\/j.clnesp.2021.08.028_bib6","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1210\/jc.2008-1595","article-title":"Obesity and the metabolic syndrome in developing countries","volume":"93","author":"Misra","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.clnesp.2021.08.028_bib7","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.18520\/cs\/v113\/i07\/1303-1310","article-title":"Non-alcoholic fatty liver disease in Asian Indians: relationship with insulin resistance, diabetes and cardiovascular risk","volume":"113","author":"Bhatt","year":"2017","journal-title":"Curr Sci"},{"issue":"3","key":"10.1016\/j.clnesp.2021.08.028_bib8","first-page":"285","article-title":"A\u00a0case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease","volume":"129","author":"Bajaj","year":"2009","journal-title":"Indian J Med Res"},{"issue":"11","key":"10.1016\/j.clnesp.2021.08.028_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142260","article-title":"Phenotype, body composition, and prediction equations (Indian fatty liver index) for non-alcoholic fatty liver disease in non-diabetic Asian Indians: a case-control study","volume":"10","author":"Bhatt","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.clnesp.2021.08.028_bib10","first-page":"729","article-title":"Diabetes risk prediction model for non-obese Asian Indians residing in North India using cut-off values for pancreatic and intra-abdominal fat volume and liver span","volume":"8","author":"Anoop","year":"2016","journal-title":"J\u00a0Diabetes"},{"key":"10.1016\/j.clnesp.2021.08.028_bib11","first-page":"351","article-title":"Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes","volume":"59","author":"Agarwal","year":"2011","journal-title":"J\u00a0Assoc Phys India"},{"issue":"7","key":"10.1016\/j.clnesp.2021.08.028_bib12","first-page":"448","article-title":"Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT)","volume":"61","author":"Kalra","year":"2013","journal-title":"J\u00a0Assoc Phys India"},{"issue":"25","key":"10.1016\/j.clnesp.2021.08.028_bib13","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.4254\/wjh.v7.i25.2597","article-title":"Dietary supplements and pediatric non-alcoholic fatty liver disease: present and the future","volume":"7","author":"Rahimlou","year":"2015","journal-title":"World J Hepatol"},{"issue":"2","key":"10.1016\/j.clnesp.2021.08.028_bib14","first-page":"281","article-title":"Fibroscan versus simple noninvasive screening tools in predicting fibrosis in high-risk nonalcoholic fatty liver disease patients from Western India","volume":"28","author":"Pathik","year":"2015","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.clnesp.2021.08.028_bib15","first-page":"163","article-title":"Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management","volume":"57","author":"Misra","year":"2009","journal-title":"J\u00a0Assoc Phys India"},{"issue":"10","key":"10.1016\/j.clnesp.2021.08.028_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140447","article-title":"Body fat patterning, hepatic fat and pancreatic volume of non-obese Asian Indians with type 2 diabetes in North India: a case-control study","volume":"10","author":"Misra","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clnesp.2021.08.028_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jcu.1870090110","article-title":"Ultrasonic determination of hepatomegaly","volume":"9","author":"Gosink","year":"1981","journal-title":"J\u00a0Clin Ultrasound"},{"issue":"9","key":"10.1016\/j.clnesp.2021.08.028_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105610","article-title":"Carotid intima-media thickness is predicted by combined eotaxin levels and severity of hepatic steatosis at ultrasonography in obese patients with Nonalcoholic Fatty Liver Disease","volume":"9","author":"Tarantino","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clnesp.2021.08.028_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7863\/ultra.33.2.197","article-title":"Shear wave elastography for evaluation of liver fibrosis","volume":"33","author":"Ferraioli","year":"2014","journal-title":"J\u00a0Ultrasound Med"},{"issue":"11","key":"10.1016\/j.clnesp.2021.08.028_bib20","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jdiacomp.2018.08.001","article-title":"Body fat, metabolic syndrome and hyperglycemia in South Asians","volume":"32","author":"Misra","year":"2018","journal-title":"J\u00a0Diabet Complicat"},{"issue":"1","key":"10.1016\/j.clnesp.2021.08.028_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13679-019-0328-0","article-title":"Obesity in South Asia: phenotype, morbidities, and mitigation","volume":"8","author":"Misra","year":"2019","journal-title":"Curr Obes Rep"},{"issue":"5","key":"10.1016\/j.clnesp.2021.08.028_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.dld.2011.12.005","article-title":"Screening for liver fibrosis by using FibroScan((R)) and FibroTest in patients with diabetes","volume":"44","author":"de Ledinghen","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"12","key":"10.1016\/j.clnesp.2021.08.028_bib23","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/liv.13481","article-title":"Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan","volume":"37","author":"Roulot","year":"2017","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.clnesp.2021.08.028_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10030159","article-title":"Non-alcoholic fatty liver disease in patients with type 2 diabetes: evaluation of hepatic fibrosis and steatosis using fibroscan","volume":"10","author":"Tuong","year":"2020","journal-title":"Diagnostics"},{"issue":"11","key":"10.1016\/j.clnesp.2021.08.028_bib25","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00592-019-01374-x","article-title":"Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients","volume":"56","author":"Mansour","year":"2019","journal-title":"Acta Diabetol"},{"issue":"2","key":"10.1016\/j.clnesp.2021.08.028_bib26","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/1932296816664916","article-title":"Estimation of liver span using MRI for prediction of type 2 diabetes in non-obese Asian Indians","volume":"11","author":"Anoop","year":"2017","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.clnesp.2021.08.028_bib27","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.dsx.2018.11.041","article-title":"High fasting C-peptide levels and insulin resistance in non-lean & non-obese (BMI >19 to < 25kg\/m(2)) Asian Indians with type 2 diabetes are independently associated with high intra-abdominal fat and liver span","volume":"13","author":"Anoop","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"10.1016\/j.clnesp.2021.08.028_bib28","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/jphp.12705","article-title":"Influence of hyperglycemia on liver inflammatory conditions in the early phase of non-alcoholic fatty liver disease in mice","volume":"69","author":"Harada","year":"2017","journal-title":"J\u00a0Pharm Pharmacol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457721003168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457721003168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:01:41Z","timestamp":1762498901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457721003168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":28,"alternative-id":["S2405457721003168"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2021.08.028","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2021.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}